Pneumatosis intestinalis after gefitinib therapy for pulmonary adenocarcinoma: a case report

Pneumatosis Intestinalis and Bowel Perforation Associated With Molecular Targeted Therapy: An Emerging Problem and the Role of Radiologists in Its Management

(2012) Atul B. Shinagare et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

Pneumatosis intestinalis and portal venous gas secondary to Gefitinib therapy for lung adenocarcinoma

(2012) Joo Young Lee et al.   BMC CANCER

Imaging features of bowel toxicities in the setting of molecular targeted therapies in cancer patients

(2012) E Thornton et al.   BRITISH JOURNAL OF RADIOLOGY

Phase I Trial of Oxaliplatin, Infusional 5-Fluorouracil, and Leucovorin (FOLFOX4) With Erlotinib and Bevacizumab in Colorectal Cancer

(2011) Wells A. Messersmith et al.   Clinical Colorectal Cancer

Pneumatosis Cystoides Intestinalis After Gefitinib Therapy for Pulmonary Adenocarcinoma

(2011) Masahiro Iwasaku et al.   Journal of Thoracic Oncology

Antiangiogenic tyrosine kinase inhibition related gastrointestinal perforations: a case report and literature review

(2010) Maudy Walraven et al.   ANGIOGENESIS

Pneumatosis intestinalis associated with treatment of cancer patients with the vascular growth factor receptor tyrosine kinase inhibitors sorafenib and sunitinib

(2010) Romain Coriat et al.   INVESTIGATIONAL NEW DRUGS

Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR

(2010) Makoto Maemondo et al.   NEW ENGLAND JOURNAL OF MEDICINE